Rita Lebano Valerio Rosato Mario Masarone Marco Romano Marcello Persico
10.1186/1756-0500-7-59
BMC Res Notes
2014 Jan 24;7:59.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24457056/
Antiviral Agents / therapeutic use Hepatitis C, Chronic / complications Purpura, Thrombocytopenic, Idiopathic / drug therapy
Antiviral Agents / therapeutic use Hepatitis C, Chronic / complications Purpura, Thrombocytopenic, Idiopathic / drug therapy Case Reports Alanine Transaminase / blood Antiviral Agents / pharmacology Aspartate Aminotransferases / blood Drug Administration Schedule Drug Therapy, Combination Female Hepatitis C, Chronic / blood Hepatitis C, Chronic / drug therapy Humans Interferon-alpha / therapeutic use Middle Aged Platelet Count Polyethylene Glycols / therapeutic use Prednisone / administration & dosage Prednisone / therapeutic use Purpura, Thrombocytopenic, Idiopathic / etiology Recombinant Proteins / therapeutic use Remission Induction Ribavirin / therapeutic use Antiviral Agents Interferon-alpha Recombinant Proteins Polyethylene Glycols Ribavirin Aspartate Aminotransferases Alanine Transaminase peginterferon alfa-2a Prednisone
PMC3915622
24457056
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report
2014